German chemicals giant BASF saw both sales and profits decline in 2019 as its upstream chemical businesses suffered.
Alexios Chronis, from CSols, examines if it is possible to cut corners when adopting a new informatics implementation project
UK life science company Abcam, headquartered in Cambridge, and University College London spinout SomaServe have joined forces to commercialise the latter’s polymer-based ‘bioic’ nanoparticles which can carry a range of products to live cells.
Trish Meek & Abigail Orozco from Thermo Fisher Scientific describe how a LIMS improved quality and regulatory compliance at a Chilean oil and gas supplier
US biotechnology company Exicure has entered into a collaboration with Allergan Pharmaceuticals International, a subsidiary of Ireland-headquartered pharmaceutical company Allergan.
Japanese pharmaceutical company Astellas Pharma and US-based bioelectronics start-up iota Biosciences have entered into a collaborative R&D agreement.
One hundred and fifty years ago, the Russian chemist Dmitri Mendeleev proposed a ‘system of elements’ ordering the known chemical elements according to their atomic weights and chemical properties.
Pharma major AstraZeneca, headquartered in Cambridge, UK, has amended its collaboration agreement with US pharmaceutical company Ironwood Pharmaceuticals. AstraZeneca now has sole responsibility for the R&D, manufacture and commercialisation of the irritable bowel syndrome (IBS) treatment Linzess in mainland China, Hong Kong and Macau.
US biotechnology company, Aldevron which produces plasmid DNA, proteins, mRNA and antibodies, is building a gene therapy manufacturing campus at its headquarters in Fargo, ND. Three buildings will be built over the next three to five years to support genetic medicine.